As of November 2026 Adaptive Biotechnologies has a market cap of NZ$8.47 Billion. This makes Adaptive Biotechnologies the world's 3257th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 9th, 2026 the market cap of Adaptive Biotechnologies was reported to be: